Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference
Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Earnings Beat: Delcath Systems, Inc. (NASDAQ:DCTH) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts [Yahoo! Finance]
Delcath Systems Inc (DCTH) Q4 2024 Earnings Call Highlights: Strong HEPZATO Revenue and ... [Yahoo! Finance]
Delcath Systems, Inc. (NASDAQ: DCTH) had its price target raised by analysts at HC Wainwright from $22.00 to $24.00. They now have a "buy" rating on the stock.